Human HSD17B13/HMFN0376/NIIL497 ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_178135.5)
Cat. No.: pGMAAV000670
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human HSD17B13/HMFN0376/NIIL497 Adeno-associated virus expression plasmid (ITR-vector) for HSD17B13 AAV packaging, HSD17B13 AAV production.The purified Human HSD17B13/HMFN0376/NIIL497 AAV particle serves as an invaluable asset for in-depth in vivo HSD17B13 studies, mechanism of action (MOA) research, and the evolution of HSD17B13-associated gene therapy strategies.
Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.
Go to
HSD17B13/HMFN0376 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMAAV000670 |
| Gene Name | HSD17B13 |
| Accession Number | NM_178135.5 |
| Gene ID | 345275 |
| Species | Human |
| Product Type | Adeno-associate virus(AAV) plasmid (overexpression) |
| Insert Length | 903 bp |
| Gene Alias | HMFN0376,NIIL497,SCDR9,SDR16C3 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Null |
| Fusion Tag | GST (C-Terminal) |
| Promoter | TBG |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGAACATCATCCTAGAAATCCTTCTGCTTCTGATCACCATCATCTACTCCTACTTGGAGTCGTTGGTGAAGTTTTTCATTCCTCAGAGGAGAAAATCTGTGGCTGGGGAGATTGTTCTCATTACTGGAGCTGGGCATGGAATAGGCAGGCAGACTACTTATGAATTTGCAAAACGACAGAGCATATTGGTTCTGTGGGATATTAATAAGCGCGGTGTGGAGGAAACTGCAGCTGAGTGCCGAAAACTAGGCGTCACTGCGCATGCGTATGTGGTAGACTGCAGCAACAGAGAAGAGATCTATCGCTCTCTAAATCAGGTGAAGAAAGAAGTGGGTGATGTAACAATCGTGGTGAATAATGCTGGGACAGTATATCCAGCCGATCTTCTCAGCACCAAGGATGAAGAGATTACCAAGACATTTGAGGTCAACATCCTAGGACATTTTTGGATCACAAAAGCACTTCTTCCATCGATGATGGAGAGAAATCATGGCCACATCGTCACAGTGGCTTCAGTGTGCGGCCACGAAGGGATTCCTTACCTCATCCCATATTGTTCCAGCAAATTTGCCGCTGTTGGCTTTCACAGAGGTCTGACATCAGAACTTCAGGCCTTGGGAAAAACTGGTATCAAAACCTCATGTCTCTGCCCAGTTTTTGTGAATACTGGGTTCACCAAAAATCCAAGCACAAGATTATGGCCTGTATTGGAGACAGATGAAGTCGTAAGAAGTCTGATAGATGGAATACTTACCAATAAGAAAATGATTTTTGTTCCATCGTATATCAATATCTTTCTGAGACTACAGAAGTTTCTTCCTGAACGCGCCTCAGCGATTTTAAATCGTATGCAGAATATTCAATTTGAAGCAGTGGTTGGCCACAAAATCAAAATGAAATGA |
| ORF Protein Sequence | MNIILEILLLLITIIYSYLESLVKFFIPQRRKSVAGEIVLITGAGHGIGRQTTYEFAKRQSILVLWDINKRGVEETAAECRKLGVTAHAYVVDCSNREEIYRSLNQVKKEVGDVTIVVNNAGTVYPADLLSTKDEEITKTFEVNILGHFWITKALLPSMMERNHGHIVTVASVCGHEGIPYLIPYCSSKFAAVGFHRGLTSELQALGKTGIKTSCLCPVFVNTGFTKNPSTRLWPVLETDEVVRSLIDGILTNKKMIFVPSYINIFLRLQKFLPERASAILNRMQNIQFEAVVGHKIKMK |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Target information
| Target ID | GM-SE0271 |
| Target Name | HSD17B13 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
345275 |
| Gene ID |
100052769 (Equus caballus), 101099712 (Felis catus), 243168 (Mus musculus), 345275 (Homo sapiens) 478468 (Canis lupus familiaris), 701104 (Macaca mulatta) |
| Gene Symbols & Synonyms | HSD17B13,Hsd17b13,Pan1b,PAN1B-like,FLDP,SCDR9,NIIL497,SDR16C3,HMFN0376 |
| Target Alternative Names | 17-beta-HSD 13,17-beta-hydroxysteroid dehydrogenase 13,FLDP,HMFN0376,HSD17B13,Hepatic retinol/retinal dehydrogenase,Hsd17b13,NIIL497,PAN1B-like,Pan1b,SCDR9,SDR16C3,Short chain dehydrogenase/reductase family 16C member 3,Short-chain dehydrogenase/reductase 9 |
| Uniprot Accession |
Q7Z5P4,Q8VCR2
Additional SwissProt Accessions: Q8VCR2,Q7Z5P4 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | |
| Disease | |
| Disease from KEGG | |
| Gene Ensembl | ENSECAG00000012765, ENSMUSG00000034528, ENSG00000170509, ENSCAFG00845015328, ENSMMUG00000019040 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


